Simplex Trading
BEAM icon

Simplex Trading’s Beam Therapeutics BEAM Stock Holding History

Simplex Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Sell
9,900
-60,900
-86% -$1.69M ﹤0.01% 4101
2025
Q4 		$1.96M Buy
70,800
+33,400
+89% +$852K ﹤0.01% 1998
2025
Q3 		$907K Buy
37,400
+15,400
+70% +$306K ﹤0.01% 3155
2025
Q2 		$374K Sell
22,000
-6,400
-23% -$111K ﹤0.01% 3820
2025
Q1 		$554K Buy
28,400
+17,000
+149% +$445K ﹤0.01% 3301
2024
Q4 		$282K Sell
11,400
-3,400
-23% -$86.8K ﹤0.01% 4130
2024
Q3 		$362K Sell
14,800
-1,400
-9% -$36.2K ﹤0.01% 3934
2024
Q2 		$379K Sell
16,200
-30,700
-65% -$754K ﹤0.01% 3954
2024
Q1 		$1.55M Buy
46,900
+22,200
+90% +$692K ﹤0.01% 2661
2023
Q4 		$672K Buy
24,700
+13,000
+111% +$323K ﹤0.01% 3402
2023
Q3 		$281K Buy
11,700
+5,700
+95% +$153K ﹤0.01% 3998
2023
Q2 		$191K Sell
6,000
-1,500
-20% -$48.7K ﹤0.01% 4342
2023
Q1 		$229K Buy
7,500
+4,000
+114% +$158K ﹤0.01% 4169
2022
Q4 		$136K Sell
3,500
-38,100
-92% -$1.71M ﹤0.01% 4700
2022
Q3 		$1.98M Buy
41,600
+28,100
+208% +$1.6M ﹤0.01% 1965
2022
Q2 		$522K Sell
13,500
-20,700
-61% -$823K ﹤0.01% 3385
2022
Q1 		$1.96M Buy
34,200
+31,800
+1,325% +$2.09M ﹤0.01% 2136
2021
Q4 		$191K Sell
2,400
-10,500
-81% -$899K ﹤0.01% 5265
2021
Q3 		$1.72M Sell
12,900
-200
-2% -$20.1K ﹤0.01% 2358
2021
Q2 		$1.69M Buy
13,100
+12,770
+3,870% +$1.02M ﹤0.01% 2399
2021
Q1 		$2.64M Buy
330
+300
+1,000% +$28.5K ﹤0.01% 1331
2020
Q4 		$244K Buy
+30
New +$1.48K ﹤0.01% 4344

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Simplex Trading's BEAM Position: Q1 2026 in Review

Simplex Trading reduced its Beam Therapeutics (BEAM) stake by 85% in Q1 2026, selling an estimated $208K and leaving 1,308 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6346.

Simplex Trading first reported a position in BEAM in Q4 2021 and has held it in 13 quarters since. The position peaked at $962K in Q2 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Simplex Trading held 1,308 shares of Beam Therapeutics worth $31.2K as of Q1 2026.
  • Simplex Trading sold 7,494 Beam Therapeutics shares in Q1 2026, an estimated $208K.
  • Beam Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6346 holding.
  • Simplex Trading first reported a position in Beam Therapeutics in Q4 2021 and has held it in 13 quarters since.
  • Simplex Trading's Beam Therapeutics position peaked at $962K in Q2 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.